[{"id":"3a5fd4f8-44a2-4aeb-8b07-da3801ece8f2","acronym":"CLAUDIO-01","url":"https://clinicaltrials.gov/study/NCT05525286","created_at":"2023-11-28T16:15:12.175Z","updated_at":"2024-07-02T16:35:00.868Z","phase":"Phase 1/2","brief_title":"Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma","source_id_and_acronym":"NCT05525286 - CLAUDIO-01","lead_sponsor":"SOTIO Biotech a.s.","biomarkers":" CLDN18","pipe":" | ","alterations":" HER-2 overexpression • HER-2 negative • CLDN18.2 expression","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 overexpression • HER-2 negative • CLDN18.2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SOT102"],"overall_status":"Recruiting","enrollment":" Enrollment 160","initiation":"Initiation: 03/31/2022","start_date":" 03/31/2022","primary_txt":" Primary completion: 12/01/2027","primary_completion_date":" 12/01/2027","study_txt":" Completion: 06/01/2028","study_completion_date":" 06/01/2028","last_update_posted":"2024-05-27"}]